SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-219015
Filing Date
2019-08-12
Accepted
2019-08-12 16:12:07
Documents
4
Period of Report
2019-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d778375d8k.htm 8-K 18029
2 EX-99.1 d778375dex991.htm EX-99.1 64340
3 GRAPHIC g778375g0809192229048.jpg GRAPHIC 26772
4 GRAPHIC g778375g0809192229188.jpg GRAPHIC 17459
  Complete submission text file 0001193125-19-219015.txt   144849
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Unum Therapeutics Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38443 | Film No.: 191016646
SIC: 2834 Pharmaceutical Preparations